Revealing the cost of Type II diabetes in Europe

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Diabetologia

• Publication date

  2002-05-24

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1007/s00125-002-0858-xPMID 27942782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Health care systems in transition

  2002cited by this paper
• Coping with Type II diabetes: the patient’s perspective

  2002cited by this paper
• Assessing the impact of complications on the costs of Type II diabetes

  2002cited by this paper
• Gesundheitsbericht für Deutschland Erste Ergebnisse einer Nutzeranalyse

  2000cited by this paper
• The progressive cost of complications in type 2 diabetes mellitus.

  1999cited by this paper
• ÉPIDÉMIOLOGIE, PRISE EN CHARGE ET COÛT DU DIABÈTE DE TYPE 2 EN FRANCE EN 1998

  1999cited by this paper
• [Epidemiology, management and costs of type 2 diabetes in France in 1998].

  1999cited by this paper
• Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Diabetes: the cost of illness in Sweden

  1998cited by this paper
• Economic Consequences of Diabetes Mellitus in the U.S. in 1997

  1998cited by this paper
• Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections

  1998cited by this paper
• The prevalence of diabetes mellitus in the Netherlands

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994

  1998cited by this paper
• The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010

  1997cited by this paper
• Health care expenditures for people with diabetes mellitus, 1992.

  1994cited by this paper
• Diabetes: a Model for Health Care Management

  1989cited by this paper
• Health care expenditures: international comparisons, 1970-80.

  1987cited by this paper
• Diabetes--the cost of illness and the cost of control. An estimate for Sweden 1978.

  1983cited by this paper

• Is a beverage tax really a healthy start? Worldwide analysis

  2025cites this paper
• Systematic Literature Review of the Impact of Type 2 Diabetes and Heart Failure Guideline Adherence on Clinical and Economic Outcomes

  2025cites this paper
• Trends in Cardiovascular Diseases and Costs Among Type 2 Diabetes Mellitus (T2DM) Patients in Malaysia: A Cohort Study of 240,611 Public Hospital Inpatients

  2024cites this paper
• Artificial sweeteners and their implications in diabetes: a review

  2024cites this paper
• Essential steps in primary care management of older people with Type 2 diabetes: an executive summary on behalf of the European geriatric medicine society (EuGMS) and the European diabetes working party for older people (EDWPOP) collaboration

  2023cites this paper
• Development of a multi-component gastroretentive expandable drug delivery system (GREDDS) for personalized administration of metformin

  2023cites this paper
• Multidisciplinary Limb Salvage Service Reduces Major Amputations in Diabetic Foot Infections.

  2023cites this paper
• Cost-Utility of an Exercise Referral Scheme Versus Doing Nothing in Flemish Adults: Exploring the Impact of Key Assumptions.

  2023cites this paper
• The burden of type 2 diabetes mellitus in states of the European Union and United Kingdom at the national and subnational levels: A systematic review

  2023cites this paper
• Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting

  2022cites this paper
• Defining explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A systematic review

  2022cites this paper
• Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures

  2021cites this paper
• Фармакоэкономическая оценка ипраглифлозина в комбинации с метформином в сравнении с другими режимами терапии сахарного диабета 2 типа

  2021cites this paper
• Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain

  2021cites this paper
• Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016–2018

  2021cites this paper
• Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study

  2020cites this paper
• Economic evaluation of surgical treatment of obesity.

  2020cites this paper
• A tale of two cinnamons: A comparative review of the clinical evidence of Cinnamomum verum and C. cassia as diabetes interventions

  2020cites this paper
• Economic Evaluation of Surgical Treatment of Obesity

  2020cites this paper
• Cost of Diabetic Foot Ulcer Management in China: A 7-Year Single-Center Retrospective Review

  2020cites this paper
• Costs analysis of diabetes mellitus: A study based on hospital invoices and diagnosis related groups

  2020cites this paper
• An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian National Health Insurance System

  2020cites this paper
• Feature Selection for Health Care Costs Prediction Using Weighted Evidential Regression

  2020cites this paper
• Fuzzy-Based Predictive Analytics for Early Detection of Diabetes

  2019cites this paper
• Epidemiological characteristics, medical costs and healthcare resource utilization of diabetes-related complications among Chinese patients with type 2 diabetes mellitus

  2019cites this paper
• Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria

  2019cites this paper
• Improving type 2 diabetes mellitus glycaemic control through lifestyle modification implementing diet intervention: a systematic review and meta-analysis

  2019cites this paper
• Direct Financial Cost of Diabetes Mellitus among Adult Sudanese Patients in Khartoum State 2016-2017

  2019cites this paper
• Efficacy, cost, and aspects to take into account in the treatment of osteoporosis in the elderly.

  2019cites this paper
• The effect of geodemographic factors on the attendance rates at a regional diabetic retinopathy treatment centre

  2019cites this paper
• Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study

  2019cites this paper
• Economic burden of diabetes in Brazil in 2014

  2019cites this paper
• The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia

  2019cites this paper
• A cost-utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada.

  2019cites this paper
• Cost-of-illness and its determinants for type 2 diabetes mellitus in Bangladesh:

  2019cites this paper
• DIRECT COSTS OF TYPE 2 DIABETES: A BRAZILIAN COST-OF-ILLNESS STUDY

  2018cites this paper
• Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit

  2018cites this paper
• Prevalence of Chronic Diabetic Complications in Newly Diagnosed versus Known Type 2 Diabetic Subjects in a Sample of Alexandria Population, Egypt.

  2018cites this paper
• Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium

  2018cites this paper
• The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17

  2018cites this paper
• Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data

  2018cites this paper
• Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia

  2018cites this paper
• Regional socio-economic factors influencing diabetes incidence: the case of Romania

  2018cites this paper
• Hospitalisation Cost of Patients with Diabetic Foot Ulcers in Valencia (Spain) in the Period 2009–2013: A Retrospective Descriptive Analysis

  2018cites this paper
• Food Preferences and Culture: The Influence of Nationality and Religion Among Tourists Visiting Goa

  2018cites this paper
• Fuzzy Goal Programming Approach for Resource Allocation in an NGO Operation

  2018cites this paper
• Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany

  2018cites this paper
• Cost analysis of type 2 diabetes mellitus treatment in economically developed countries

  2018cites this paper
• Aging and Diabetes: Impact on Employment and Retirement

  2017cites this paper
• Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014

  2017cites this paper
• Prevalence and progression rate of diabetic retinopathy in type 1 diabetes patients in correlation with the duration of diabetes

  2017cites this paper
• Increased cost of illness among European patients with type 2 diabetes treated with insulin

  2017cites this paper
• Approaches to Integrated Diabetes Care: A South African Approach

  2017cites this paper
• The Economic Impact of Blindness in Europe

  2017cites this paper
• New method of sudomotor function measurement to detect microvascular disease and sweat gland nerve or unmyelinated C fiber dysfunction in adults with retinopathy

  2017cites this paper
• COST-EFFECTIVENESS ANALYSIS OF TYPE 2 DIABETES IN OUTPATIENT THERAPY IN TURKEY TİP 2

  2017cites this paper
• Is quality of life different between diabetic and non-diabetic people? The importance of cardiovascular risks

  2017cites this paper
• Nivel de conocimientos sobre la Diabetes Mellitus en un grupo de pacientes diabéticos relacionado con la presencia de complicaciones secundarias.

  2017cites this paper
• The cost of severe haemophilia in Europe: the CHESS study

  2017cites this paper
• Audit report of the HSE Midland Diabetes Structured Care Programme

  2017cites this paper
• Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece

  2017cites this paper
• Diabetes and Cardiovascular Disease CARDIOVASCULAR DISEASE AND THE DIABETES MELLITUS EPIDEMIC Consequences of the modern lifestyle ?

  2017cites this paper
• What Socioeconomic Factors Explain Type 2 Diabetes Prevalence

  2017cites this paper
• Fracture Risk Assessment in Patients With Diabetes Mellitus.

  2017cites this paper
• Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes: A long-term follow-up in clinical practice.

  2017cites this paper
• The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach

  2017cites this paper
• Paclitaxel‐coated balloon reduces target lesion revascularization compared with standard balloon angioplasty

  2017cites this paper
• A CTUALIZACIÓN E N D IABETES Y E NFERMEDAD C ARDIOVASCULAR

  2016cites this paper
• Open Surgical versus Minimal Invasive Necrosectomy of the Pancreas—A Retrospective Multicenter Analysis of the German Pancreatitis Study Group

  2016cites this paper
• Carga epidemiológica y económica de la hipertensión arterial en pacientes con síndrome metabólico en Espaun modelo basado en la prevalencia

  2016cites this paper
• Estimating the Economic Cost of Obesity in Canadian Populations

  2016cites this paper
• Risk Factors for Macro- and Microvascular Complications among Older Adults with Diagnosed Type 2 Diabetes: Findings from The Irish Longitudinal Study on Ageing

  2016cites this paper
• O NE DAY U PDATE I N D IABETES A ND C ARDIOVASCULAR D ISEASES

  2016cites this paper
• DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus. Expectations, observations and perspectives.

  2016cites this paper
• Cost of diabetes in Norway 2011.

  2016cites this paper
• Costs for Hospitalized Patients With Diabetes Mellitus in China

  2015influential citation
• Lipid profile and micro- and macrovascular complications in type 1 diabetes

  2015cites this paper
• Assays for Insulin and Insulin-Like Metabolic Activity Based on Hepatocytes, Myocytes and Diaphragms

  2015cites this paper
• Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis

  2015cites this paper
• Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative

  2015cites this paper
• The Cost of Managing Type 2 Diabetes Mellitus in Greece: A Retrospective Analysis of 10-Year Patient Level Data “The HERCULES Study”

  2015cites this paper
• [Self-care assessment in type-2 diabetes: the Italian translation and validation of the Summary of Diabetes Self-Care Activities].

  2015cites this paper
• Impact of high-intensity interval training on HbA1c in patients with type 2 diabetes mellitus

  2015cites this paper
• PSYCHOLOGICAL SUPPORT OF PATIENTS WITH DIABETES TYPE 1- ROLE AND PARTICIPATION OF NURSE

  2015cites this paper
• Imbalance in inpatient costs between urban and rural diabetes patients in Jinan, China

  2015cites this paper
• A Systematic Review of the Economic and Humanistic Burden of Gout

  2015cites this paper
• The Economic Costs of Type 2 Diabetes: A Global Systematic Review

  2015cites this paper
• The global impact of non-communicable diseases on healthcare spending and national income: a systematic review

  2015cites this paper
• Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting.

  2015cites this paper
• Counting the Cost of Diabetes in the Solomon Islands and Nauru

  2015cites this paper
• Health Economic Evaluation of Type 2 Diabetes Mellitus: A Clinical Practice Focused Review

  2015cites this paper
• Prevalence trends in lifestyle-related risk factors.

  2015cites this paper
• Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain

  2015cites this paper
• Valutazione del self-care nelle persone con diabete di tipo 2: traduzione e validazione della Summary of Diabetes Self-Care Activities Self-care assessment in type 2 diabetes patients: Italian translation and validation of the Summary of Diabetes Self-Care Activities

  2015cites this paper
• Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina

  2014cites this paper
• Assessment of the Direct Medical Costs of Type 2 Diabetes Mellitus and its Complications in Turkey

  2014cites this paper
• De frequentie en impact van niet-ernstige hypoglycemie bij insulinegebruik in Nederland

  2014cites this paper
• Consenso latino-americano de hipertensão em pacientes com diabetes tipo 2 e síndrome metabólica

  2014cites this paper
• Impact of a 12-week, pharmacist-directed walking program in an established employee preventive care clinic.

  2014cites this paper
• What Works in Community-Based Interventions Promoting Physical Activity and Healthy Eating? A Review of Reviews

  2014cites this paper